Lactobacillus rhamnosus was first isolated in 1983 and is known to have a strong avidity for human intestinal cells and can survive acid and bile environments. It is considered one of the most studied probiotics, with research showing that it could do the following:
- alleviate rotavirus diarrhea in children,
- prevent atopic dermatitis,
- protect against urinary tract infections,
- and improve symptoms of irritable bowel syndrome.
Lactobacillus rhamnosus appears to be safe and effective in prolonging remission in UC patients. LGG has also been studied in CD, but found to be no better than placebo.
References:
Inflammatory Bowel Disease. / Parian, Alyssa M.; Mullin, Gerard E.; Langhorst, Jost; Brown, Amy C., Integrative Medicine: Fourth Edition. Elsevier, 2018.
Lactobacillus rhamnosus
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →
All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.